In Vivo Forward Genetic CRISPR Screens for Glaucoma Modifiers
This project addresses glaucoma, one of the most common causes of blindness, and brings together a neuroscientist/eye researcher and a bioengineer with expertise in the development of CRISPR genome engineering technologies. The team will deploy CRISPR in an in vivo genome-wide screen for modifiers of optic nerve degeneration in mouse glaucoma models, taking advantage of the accessibility of the visual system in the mouse models for screening and intervention. Genes and pathways identified for glaucoma could also eventually point to pathways relevant for other neurodegenerative diseases.
This project was selected for the second phase of the Collaborative Pairs RFA.